Page last updated: 2024-10-21

5-hydroxydecanoate and Brain Diseases

5-hydroxydecanoate has been researched along with Brain Diseases in 1 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research Excerpts

ExcerptRelevanceReference
"Rats were exposed to 90 minutes of middle cerebral artery occlusion followed by 72 hours of reperfusion."1.38Protective effect of delayed remote limb ischemic postconditioning: role of mitochondrial K(ATP) channels in a rat model of focal cerebral ischemic reperfusion injury. ( Deng, J; Dong, H; Li, Y; Li, Z; Luan, Q; Sun, J; Tong, L; Xiong, L, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, J1
Tong, L1
Luan, Q1
Deng, J1
Li, Y1
Li, Z1
Dong, H1
Xiong, L1

Other Studies

1 other study available for 5-hydroxydecanoate and Brain Diseases

ArticleYear
Protective effect of delayed remote limb ischemic postconditioning: role of mitochondrial K(ATP) channels in a rat model of focal cerebral ischemic reperfusion injury.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2012, Volume: 32, Issue:5

    Topics: Animals; Anti-Arrhythmia Agents; Apoptosis; Brain Diseases; Decanoic Acids; Hydroxy Acids; Infarctio

2012